BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease
Search BioPortfolio:       

«Transgene

Below is an extended Transgene patents listing. Click here to return to the Transgene main Biocorporate entry.

Transgene Patents :

US Patent No.Title
6277601 Expression of a foamy virus envelope protein
6407178 Cationic polymers, complexes associating said cationic polymers with therapeutically active substances comprising at least a negative charge, in particular nucleic acids, and their use in gene therapy
6451256 Method for preserving infectious recombinant viruses, aqueous viral suspension and use as medicine
6475480 Use of adenoviral E4 reading frames to improve expression of a gene of interest
6479290 Chimeric adenoviral vectors
6514756 Human myoblast cell lines and their uses
6528312 Use of G-actin for improving transfection of a polynucleotide into a cell
6555377 Process for production of mammalian cell lines
6569677 Modified adenoviral fiber and target adenoviruses
6582694 Method for preparing a viral aerosol
6596533 Mutant having uracil phosphoribosyl transferase activity
6399587 Recombinant adenoviral vectors comprising a splicing sequence
6372443 Cassette for expressing a toxoplasma gondii P30 protein
6350575 Helper viruses for the preparation of recombinant viral vectors
6277822 Family of peptides known as xenoxins
6281000 Method for the preparation of a viral vector by intermolecular homologous recombination
6284248 Immunogenic compositions comprising soluble, non-cleavable, chimeric HIV-1 gp160-variants
6284252 Transdominant TAT variants of the human immunodeficiency virus
6291423 Lipid complexes for transferring at least a therapeutically active substance, in particular a polynucleotide into a target cell and use in gene therapy
6326350 Transferrin receptor subunit proteins of Neisseria meningitidis
6328956 Pharmaceutical composition for the treatment or prevention of a malignant tumor
6335199 Lipid compounds and compositions containing same used for the transfer of at least an active substance, in particular a polynucleotide, in a target cell and therapeutic use
6344194 Method for preparing a viral aerosol and its use in gene therapy treatment
6346414 Transposition assembly for gene transfer in eukaryotes
6656734 Compositions for the delivery of polynucleotides to cells
6692956 Recombinant adenoviral vectors
7067309 Defective adenoviruses and corresponding complementation lines
7067310 Method for the preparation of a viral vector by inter-molecular homologous recombination
7118754 Pharmaceutical composition for treating papillomavirus tumors and infection
7148341 AAV DNA comprising helper virus sequences
7256036 Modified adenoviral fiber and target adenoviruses
7264958 Method for obtaining a purified viral preparation
7332478 Antitumoral composition based on immunogenic polypeptide with modified cell location
7348014 Poxvirus with targeted infection specificity
7354591 Poxvirus with targeted infection specificity
7378265 Method of inactivating enveloped viruses in a viral preparation of non-enveloped viruses
7049117 Mutant possessing uracil phosphoribosyl transferase activity
7033779 Method for preparing steroids modified by yeast fermentation
7026299 Connective tissue growth factor-2
6703226 Expression of a foamy virus envelope protein
6723708 Use of lithium (Li+) for the preparation of a composition for transfection of a polynucleotide into a cell and compositions useful in gene therapy
6740511 Modified adenoviral fibre and uses thereof
6743781 Glycerolipid compounds useful for the transfer of an active substance into a target cell
6881724 Use of magnesium (Mg2+) for the preparation of a therapeutic composition for transfection of a polynucleotide into a cell and compositions useful in gene therapy
6884786 Antitumoral composition based on immunogenic polypeptide with modified cell location
6906041 Treatment of immune diseases
6960469 Adenoviral vectors encoding an antibody fused to a CD4 extracellular domain
7005277 Defective adenoviruses and corresponding complementation lines
7026154 Method of inactivating enveloped viruses in a viral preparation of non-enveloped viruses
7393831 Peptide compositions and their use against HCV

«Transgene

This page contained an extended Transgene patents listing. Click here to return to the Transgene main Biocorporate entry.

 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright 1997-2008 - BioPortfolio Limited.